Marksans Pharma announced USFDA final approval of the Company's wholly owned subsidiary Marksans Pharma Inc.'s Abbreviated New Drug Application (ANDA) for Loperamide Hydrochloride Tablets USP, 2 mg ...
Marksans Pharma announced that its wholly owned subsidiary, Marksans Pharma Inc., has received final approval from the USFDA for its abbreviated new drug application (ANDA) for Loperamide ...
Marksans Pharma said the Loperamide Hydrochloride tablet is an anti-diarrheal medication used to control symptoms of acute ...
Mumbai: Marksans Pharma Limited has announced that its wholly owned subsidiary, Marksans Pharma Inc., has received final ...
In 2024, the U.S. FDA granted HYRNUO Breakthrough Therapy designation for the treatment of adult patients with unresectable or metastatic NSCLC whose tumors have activating HER2 (ERBB2) mutations, and ...
One of the common signs they may be better off at home is a high temperature and with other illnesses, such as diarrhoea and ...
Trial participants who used eloralintide, a new weight loss medication that, instead of focusing on the hormone GLP-1, ...
Findings showed treatment with D-VCd significantly improved MOD-PFS and OS vs treatment with VCd.
Regeneron's EYLEA HD injection 8 mg approved by FDA for the treatment of macular edema following RVO
The US Food and Drug Administration (FDA) has approved aflibercept injection 8 mg (EYLEA HD) from Regeneron Pharmaceuticals ...
Nutraceuticals and functional foods, known for their ability to provide health advantages beyond basic nutrition, are gaining ...
The Marburg Virus Disease Therapeutics Market in the U.S. is projected to experience consistent growth from 2025 to 2035. With an estimated market size of USD 100.9 Million in 2025, the market is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback